Neuroendocrinology of the polycystic ovary syndrome

Bailliere's Clinical Endocrinology and Metabolism

Volumn 10, Issue 2, 1996, Pages 205-219

  Soule, S G ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; DOPAMINE; ENDORPHIN; ESTROGEN; ESTRONE; FOLLITROPIN; GONADORELIN; GONADOTROPIN; INSULIN; LUTEINIZING HORMONE; NEUROTRANSMITTER; PROGESTERONE; SEROTONIN;

FEEDBACK SYSTEM; FEMALE; GLYCOSYLATION; GONADOTROPIN RELEASE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; NEUROENDOCRINOLOGY; NORADRENERGIC SYSTEM; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; REVIEW;

EID: 0029889258     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(96)80071-1     Document Type: Article

References (59)

1. Adashi EY Hypothalamic-pituitary dysfunction in polycystic ovary disease Endocrinology and Metabolism Clinics of North America 17 1988 549 666
2. Adashi EY Hsueh AJW Yen SSC Insulin enhancement of LH and FSH release by cultured pituitary cells Endocrinology 108 1981 1441 1449
3. Aleem FA McIntosh T Elevated plasma levels of β-endorphin in a group of women with polycystic ovarian disease Fertility and Sterility 42 1984 686 689
4. Balen AH Jacobs HS Gonadotrophin Surge Attenuating Factor: a missing link in the control of LH secretion? Clinical Endocrinology 35 1991 399 402
5. Balen AH Tan SL Jacobs HS Hypersecretion of luteinising hormone-a significant cause of infertility and miscarriage British Journal of Obstetrics and Gynaecology 100 1993 1082 1089
6. Barkan AL Regiani S Duncan JA Opioids modulate pituitary receptors for GnRH Endocrinology 112 1983 387 389
7. Barnes RB Mileikowsky GN Cha KY Effects of dopamine and metoclopramide in polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 63 1986 506 509
8. Berga SL Yen SSC Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome Clinical Endocrinology 30 1989 177 184
9. Berga SL Guzick DS Winters SJ Increased LH and a-subunit secretion in women with hyperandrogenic anovulation Journal of Clinical Endocrinology and Metabolism 77 1993 895 901
10. Blankstein J Rabinovici J Goldenberg M Changing pituitary reactivity to follicle-stimulating hormone and luteinising hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease Journal of Clinical Endocrinology and Metabolism 65 1987 1164 1167
11. Cagnacci A Soldani R Paoletti AM Prolonged opioid blockade with naltrexone and luteinising hormone modifications in women with polycystic ovary syndrome Fertility and Sterility 62 1994 269 272
12. Chang RJ Mandel FP Lu JKH Judd HL Enhanced disparity of gonadotrophin secretion of estrone in women with polycystic ovarian disease American Journal of Obstetrics and Gynecology 54 1982 490 494
13. Chang RJ Laufer LR Meldrum DR Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting GnRH agonist Journal of Clinical Endocrinology and Metabolism 56 1983 897 903
14. Christman GM Randolph JF Kelch RP Marshall JC Reduction of GnRH pulse frequency is associated with subsequent selective follicle stimulating hormone secretion in women with polycystic ovarian disease Journal of Clinical Endocrinology and Metabolism 72 1991 1278 1285
15. Chrousos GP Loriaux DL Mann DL Cutler GB Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease Annals of Internal Medicine 96 1982 143 148
16. Conway GS Honour JW Jacobs HS Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients Clinical Endocrinology 30 1989 459 470
17. Cumming DC Reid RL Quigley ME Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome Clinical Endocrinology 20 1984 643 648
18. Danforth DR Cheng CY Purification of a candidate gonadotrophin surge inhibiting factor from porcine follicular fluid Endocrinology 136 1995 1658 1665
19. Donesky BW Adashi EY Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy Fertility and Sterility 63 1995 439 463
20. Dunaif A Do androgens directly regulate gonadotrophin secretion in the polycystic ovary syndrome? Journal of Clinical Endocrinology and Metabolism 63 1986 215 221
21. Dunaif A Futterweit W Polycystic ovary syndrome New England Journal of Medicine 319 1988 584
22. Dunaif A Scully RE Andersen RN The effects of continuous androgen secretion on the hypothalamic-pituitary axis in women: evidence from a luteinised ovarian thecoma Journal of Clinical Endocrinology and Metabolism 59 1984 389 393
23. Fauser BCJM Pache TD Hop WCJ The significance of a single LH measurement in women with cycle disturbances: disrepancies between immunoreactive and bioactive hormone estimates Clinical Endocrinology 37 1992 445 452
24. Filicori M Flamagni Hypothalamic-pituitary abnormalities in polycystic ovary syndrome Hershmann JM Current Issues in Endocrinology and Metabolism 1992 Blackwell Scientific Publications Oxford 31 38
25. Franks S Polycystic ovary syndrome: a changing perspective Clinical Endocrinology 31 1989 87 120
26. Futterweit W Pathophysiology of polycystic ovary syndrome Redmond GP Androgenic Disorders 1995 Raven Press Boston 77 166
27. Hall JE Polycystic ovarian disease as a neuroendocrine disorder of the female reproductive axis Endocrinology and Metabolism Clinics of North America 22 1993 75 92
28. Hall JE Whitcomb RW Rivier JE Differential regulation of LH, FSH, and free a-subunit secretion from the gonadotroph by GnRH: evidence from the use of two GnRH agonists Journal of Clinical Endocrinology and Metabolism 70 1990 328 335
29. Jacobs HS Polycystic ovary syndrome: aetiology and management Current Opinion in Obstetrics and Gynaecology 7 1995 203 208
30. Lambert-Messerlian GM Hall JE Sluss PM Relatively low levels of inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay Journal of Clinical Endocrinology and Metabolism 76 1994 45 50
31. Lobo RA The role of neurotransmitters and opioids in polycystic ovary syndrome Endocrinology and Metabolism Clinics of North America 17 1988 667 683
32. Lobo RA Granger L Goebelsmann U Mishell DR Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotrophin secretion in women with PCO Journal of Clinical Endocrinology and Metabolism 52 1981 156 158
33. Lobo RA Kletsky OA Campeau JD dizerega GS Elevated bioactive luteinising hormone in women with the polycystic ovary syndrome Fertility and Sterility 39 1983 674 678
34. Lobo RA Granger LR Wellington LP Psychological stress and increases in urinary norepinephrine metabolite, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome American Journal of Obstetrics and Gynecology 145 1983 496 503
35. McKenna TJ Pathogenesis and treatment of polycystic ovary syndrome New England Journal of Medicine 318 1988 558 562
36. Melis GB Paoletti AM Gambacciani M Evidence that oestrogens inhibit LH secretion through opioids in postmenopausal women using naloxone Neuroendocrinology 39 1984 60 63
37. Merriam GR Neuroendocrine abnormalities in polycystic ovary syndrome: an overview Hershmann JM Current Issues in Endocrinology and Metabolism 1992 Blackwell Scientific Publications New York 1 56
38. Millar RP Klaff LJ Barron J Somatostatin-28 inhibits LHRH-stimulated gonadotrophin secretion in man Clinical Endocrinology 17 1982 103 107
39. Paradisi R Venturoli S Capelli M Effects of a-energic blockade on pulsatile LH, FSH and prolactin secretion in polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 65 1987 841 846
40. Poretsky L On the paradox of insulin-induced hyperandrogenism in insulin-resistant states Endocrine Reviews 12 1991 3 13
41. Prelevic GM Wurzburger MI Balint-Peric L Nesic JS Inhibitory effect of sandostatin on luteinising hormone and ovarian steroids in polycystic ovary syndrome Lancet 336 1990 900 903
42. Quigley ME Rakoff JS Yen SSC Increased luteinising hormone sensitivity to dopamine inhibition in polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 52 1981 231 234
43. Rebar R Judd HL Yen SSC Characterisation of the inappropriate gonadotrophin secretion in polycystic ovary syndrome Journal of Clinical Investigation 57 1976 1320 1329
44. Rosen GF Lobo RA Further evidence against dopamine deficiency as a cause of inappropriate gonadotrophin secretion in patients with polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 65 1987 891 895
45. Rossmanith WG Keckstein J Spatzier K Lauritzen C The impact of ovarian laser surgery on the gonadotrophin secretion in women with polycystic ovarian disease Clinical Endocrinology 34 1991 223 230
46. Scheele F Hompes PGA Gooren LJG The effect of 6 weeks of testosterone treatment on pulsatile LH secretion in eugonadal female to male transexuals Fertility and Sterility 55 1991 608 611
47. Serafini P Silva PD Paulsen RJ Acute modulation of the hypothalamic-pituitary axis by intravenous testosterone in normal women American Journal of Obstetrics and Gynecology 155 1986 1288 1292
48. Shoham Z Conway GS Patel A Jacobs HS Polycystic ovaries in patients with hypogonadotrophic hypogonadism: similarity of ovarian response to gonadotrophin stimulation in patients with polycystic ovarian syndrome Fertility and Sterility 58 1992 37 45
49. Shoupe D Lobo RA Evidence for altered catecholamine metabolism in polycystic ovary syndrome American Journal of Obstetrics and Gynecology 150 1984 566 571
50. Shoupe D Montz FJ Lobo RA The effects of oestrogen and progestin on endogenous opioid activity in oophorectomised women Journal of Clinical Endocrinology and Metabolism 60 1985 178 183
51. South SA Yankov VI Evans WS Normal reproductive neuroendocrinology in the female Endocrinology and Metabolism Clinics of North America 22 1993 1 28
52. Speight A Fink G Comparison of steroid and LH-RH effects on the responsiveness of hemipituitary glands and dispersed pituitary cells Molecular and Cellular Endocrinology 24 1981 267 275
53. Spratt DI Finkelstein JS Butler JP Effects of increasing the frequency of low doses of GnRH on gonadotrophin secretion in GnRH-deficient men Journal of Clinical Endocrinology and Metabolism 64 1987 1179 1186
54. Steingold KA Lobo RA Judd HL The effect of bromocriptine on gonadotrophin and steroid secretion in polycystic ovarian disease Journal of Clinical Endocrinology and Metabolism 62 1986 1048 1051
55. Waldstreicher J Santoro NF Hall JE Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitisation Journal of Clinical Endocrinology and Metabolism 66 1988 165 172
56. Whitcomb RW O'Dea LS Finkelstein JS Utility of free alpha subunit as an alternative marker of GnRH stimulation of the gonadotroph in the human: evidence from normal and GnRH deficient men Journal of Clinical Endocrinology and Metabolism 79 1990 1654 1661
57. Yamato M Minami S Nakano R Immunohistochemical localisation of inhibin subunits in polycystic ovary Journal of Clinical Endocrinology and Metabolism 77 1993 859 862
58. Yen SSC Lasley BL Wang CF The operating characteristics of the hypothalamic—pituitary system during the menstrual cycle and observation of biological action of somatostatin Recent Progress in Hormone Research 31 1975 321 363
59. Zumoff B Freeman R Coupey S A chronobiologic abnormality in luteinising hormone secretion in teenage girls with the polycystic ovary syndrome New England Journal of Medicine 309 1983 1206 1209